Sponsored Yesterday, The Basile Law Firm P.C. announced that its’ client, 5BARz International Inc., (OTC: BARZ) filed a motion in the United States Circuit Court of Appeals for the Second Circuit to certify questions of law to the New York Court of Appeals requesting that several issues of unsettled state usury law be put in front of the New York
Read more
In a recent guest post, Mark R. Basile, Esq. shared a post titled “Let’s Make A Deal! – A Message to Convertible Note Holders And MicroCap CEOs.” In the post, Basile discussed how it is becoming increasingly difficult to clear stock in microcap companies, especially if that stock was part of a note conversion. So, what can you do if
Read more
Guest Post By Mark R. Basile, Esq. Turns out that Friday the 13th is also unlucky for toxic convertible note-holders! I have been warning the toxic convertible note industry that there was going to be a reckoning with regard to how they lend money to microcap OTC Markets companies, and now, it seems that the chickens are coming home to roost.
Read more
This year, we were honored to have some of the foremost experts in the microcap space share guest posts with us. From microcap fundraising to investor relations, we shared over a dozen guest posts from microcap attorneys, investors, CEOs, and other service providers. On a sad note, one of our earliest guest contributors, Tom Allinder, passed away a few months
Read more
In September, two New York law firms, The Basile Law Firm P.C. and Phillipson & Uretsky, LLP announced that they have opened an investigation into a potential class action lawsuit against New York based lenders of short-term loans to microcap companies trading on the OTC Market. We checked in with Mark Basile, Esq. (of The Basile Law Firm P.C.)
Read more
Today, two New York law firms, The Basile Law Firm P.C. and Phillipson & Uretsky, LLP announced that they have opened an investigation into a potential class action lawsuit against New York based lenders of short-term loans to microcap companies trading on the OTC Market. The class action being investigated and considered is on behalf of OTC Market public microcap
Read more
Again, a lot of this goes back to the root of all microcap evil, toxic lending, irrevocable transfer agent letters and your transfer agency agreements. Recently, I spoke with a CEO who wanted to terminate his company’s transfer agent because the transfer agent refused to follow his instructions as well as the T/A providing confidential information to third parties without consent of the client, and in all likelihood, breaching the non-disclosure clauses in their own transfer agency contracts.
Read more
Guest Post By: Mark R. Basile, Esq. There are many forms of terrorism in this world playing out right before us and we are all somewhat familiar with the political form, but what about the economic form. While there is no one specific definition of terrorism as applied to business, I have seen many companies fall victim to what I call
Read more
Guest Post By: Mark R. Basile, Esq. Ok, its summer, the sun is shining, the waves are crashing on the beach and you are now in what’s called the OTC CEO summer doldrums because those things are happening for everyone else except you. And if you are lucky enough to be able to take your family on a summer vacation,
Read more
Guest Post By: Mark R. Basile, Esq. There are two sides to the position of OTC (microcap) CEO pay. Either you should have the privilege to work for free for shareholders and investors, or you can be a real professional and pay yourselves a reasonable salary. If you want to raise real money, pay yourself. I can’t begin to tell you
Read more